27 related articles for article (PubMed ID: 7686558)
1. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.
Mathew A; Cheng HM; Sam CK; Joab I; Prasad U; Cochet C
Cancer Immunol Immunother; 1994 Jan; 38(1):68-70. PubMed ID: 8299121
[TBL] [Abstract][Full Text] [Related]
2. Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma.
Cheng HM; Foong YT; AbuSamah AJ; Dillner J; Sam CK; Prasad U
Cancer Immunol Immunother; 1995 Apr; 40(4):251-6. PubMed ID: 7750123
[TBL] [Abstract][Full Text] [Related]
3. Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer.
Li T; Li F; Guo X; Hong C; Yu X; Wu B; Lian S; Song L; Tang J; Wen S; Gao K; Hao M; Cheng W; Su Y; Zhang S; Huang S; Fang M; Wang Y; Ng MH; Chen H; Luo W; Ge S; Zhang J; Xia N; Ji M
N Engl J Med; 2023 Aug; 389(9):808-819. PubMed ID: 37646678
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening.
Chen VHE; Ong L; Teo WK; Siow CH; Goh HL; Tan C; Lim WS; Eu D; Cheong ISY; Chan SH; Loh KS; Tay JK
Head Neck; 2024 May; ():. PubMed ID: 38817018
[TBL] [Abstract][Full Text] [Related]
5. VCA in the Era of the COVID-19 Pandemic.
Petruzzo P; Kanitakis J; Sardu C; Bassiri Gharb B; Morelon E; Amer H; Barret J; Burt J; Brandacher G; Gomez T; Kay S; Kaminska D; Kaufman CL; Kumar DS; Iglesias M; Iyer S; Landin L; Lanzetta M; Lassus P; Levin S; Papay F; Pomahac B; Sassu P; Satbhai NG; Talbot S;
Transplantation; 2022 Apr; 106(4):690-692. PubMed ID: 35333847
[No Abstract] [Full Text] [Related]
6. Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma: a meta-analysis.
Li S; Deng Y; Li X; Chen QP; Liao XC; Qin X
Chin Med J (Engl); 2010 May; 123(9):1201-5. PubMed ID: 20529563
[TBL] [Abstract][Full Text] [Related]
7. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.
Foong YT; Cheng HM; Sam CK; Dillner J; Hinderer W; Prasad U
Int J Cancer; 1990 Jun; 45(6):1061-4. PubMed ID: 1693600
[TBL] [Abstract][Full Text] [Related]
8. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
[TBL] [Abstract][Full Text] [Related]
9. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
10. Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up.
Shimakage M; Dezawa T; Chatani M
Acta Otolaryngol; 2000 Jan; 120(1):100-4. PubMed ID: 10779195
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
[TBL] [Abstract][Full Text] [Related]
12. Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay.
Cheng HM; Foong YT; Mathew A; Sam CK; Dillner J; Prasad U
J Virol Methods; 1993 Apr; 42(1):45-51. PubMed ID: 7686558
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Serum Epstein-Barr Virus Capsid Antigen-IgA for Nasopharyngeal Carcinoma: a Meta-Analysis Based on 21 Studies.
Chen Y; Xin X; Cui Z; Zheng Y; Guo J; Chen Y; Lin Y; Su G
Clin Lab; 2016; 62(6):1155-66. PubMed ID: 27468579
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
